Hepatitis C Patient Journey: The Impact on Quality of Life

In part six, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how hepatitis C impacts the entire body.
PUBLISHED THURSDAY, OCTOBER 15, 2015
In part six, Jim Wilson, RPh, MBA, president of WilsonRx, discusses  how hepatitis C impacts the entire body.



 
Recommended Articles
Study finds a common assortment of reasons for non-initiation of HCV therapy, regardless of patient race or ethnicity.
Managing the risk of hepatitis C and liver disease among infants born to mothers with chronic HCV is a challenge.
HCV patients with cirrhosis and severe sepsis face elevated risk of organ failure.
Anti-retroviral drug therapy may effectively treat hepatitis C-HIV coinfection.
$auto_registration$